HomeAI · summaries
Storia in 3 fonti
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss
A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down over the long term.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options
Reducing the dose of Eli Lilly’s obesity shot Zepbound could provide a safe, effective and potentially cheaper option for the maintenance of weight loss, according to new data.
- ·
biopharmadive.com
Lilly data point to ‘maintenance’ strategies for GLP-1 weight loss
A pair of trial results published in medical journals suggest switching from high-dose injectables to lower doses or pills could help people with obesity keep their weight down…
- ·
fiercepharma.com
The Oral GLP-1 Tracker: Wegovy pill total scripts down for first time
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. | Fierce Pharma is launching the…